Loading clinical trials...
Loading clinical trials...
Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With Fever of Unknown Origin: a Randomized Multicenter Non-inferiority Trial.
Conditions
Interventions
Discontinuation of imipenem-cilastatin or meropenem
Locations
2
Netherlands
VU university medical center
Amsterdam, Netherlands
HAGA ziekenhuis
The Hague, Netherlands
Start Date
December 1, 2014
Primary Completion Date
August 5, 2019
Completion Date
August 5, 2019
Last Updated
September 25, 2019
NCT05537896
NCT04841447
NCT06293677
NCT06787326
NCT07277387
NCT04948463
Lead Sponsor
Amsterdam UMC, location VUmc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions